Aurinia Pharmaceuticals (AUPH) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Aurinia Pharmaceuticals, a leader in autoimmune disease therapies, will unveil its second-quarter financial and operational results on August 1, 2024. The announcement will be followed by a conference call and webcast led by the management team to discuss the outcomes and provide business updates. This pivotal update is expected to draw significant attention from investors and market watchers.
For further insights into AUPH stock, check out TipRanks’ Stock Analysis page.